GBV-006

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGBV-006
Drug Alias NameGBV-006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitorsVirus internalization inhibitors
TargetsNot applicable
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A